Uti Healthcare Fund Datagrid
Category Pharma Fund
BMSMONEY Rank -
Rating
Growth Option 13-03-2026
NAV ₹276.65(R) -1.89% ₹313.92(D) -1.89%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 8.27% 25.26% 14.94% 18.52% 11.84%
Direct 9.34% 26.49% 16.13% 19.72% 12.96%
Nifty Pharma TRI 12.8% 26.24% 14.52% 14.92% 7.65%
SIP (XIRR) Regular -3.23% 13.26% 14.8% 17.4% 15.54%
Direct -2.26% 14.45% 15.98% 18.63% 16.69%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
1.22 0.65 1.02 2.4% -0.41
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
15.79% -17.42% -15.36% 0.88 11.03%
Fund AUM As on: 30/12/2025 1118 Cr
Top Pharma Fund
Fund Name Rank Rating
Mirae Asset Healthcare Fund -

NAV Date: 13-03-2026

Scheme Name NAV Rupee Change Percent Change
UTI Healthcare Fund - Regular Plan - IDCW 213.81
-4.1300
-1.8900%
UTI Healthcare Fund - Direct Plan - IDCW 242.64
-4.6800
-1.8900%
UTI Healthcare Fund - Regular Plan - Growth Option 276.65
-5.3400
-1.8900%
UTI Healthcare Fund - Direct Plan - Growth Option 313.92
-6.0500
-1.8900%

Review Date: 13-03-2026

Beginning of Analysis

The 5 star rating shows an excellent past performance of the Uti Healthcare Fund in Pharma Fund. The Uti Healthcare Fund has a Jensen Alpha of 2.4% which is higher than the category average of 1.56%. Here the Uti Healthcare Fund has shown good performance in terms of risk adjusted returns. The Uti Healthcare Fund has a Sharpe Ratio of 1.22 which is higher than the category average of 1.19. Here the Uti Healthcare Fund has shown good performance in terms of risk adjusted returns.
The past performance of the {fund_name_eng} may or may not be sustained in the future. The review is not investment advice nor is it a recommendation to buy or sell funds.
Pharma Mutual Funds

Uti Healthcare Fund Return Analysis

The Uti Healthcare Fund has delivered a mixed performance across various time horizons, showcasing both strengths and challenges when compared to its Pharma Fund peers and the Nifty Pharma TRI benchmark. This analysis examines the fund’s returns over periods ranging from one month to ten years, alongside its Systematic Investment Plan (SIP) performance, highlighting its rankings within the Pharma Fund category and its ability to outperform or underperform the benchmark and category averages.

  • The fund has given a return of -0.88%, -3.16 and -5.89 in last one, three and six months respectively. In the same period the category average return was -0.15%, -2.19% and -3.48% respectively.
  • Uti Healthcare Fund has given a return of 9.34% in last one year. In the same period the Nifty Pharma TRI return was 12.8%. The fund has given 3.46% less return than the benchmark return.
  • The fund has given a return of 26.49% in last three years and rank 3rd out of six funds in the category. In the same period the Nifty Pharma TRI return was 26.24%. The fund has given 0.25% more return than the benchmark return.
  • Uti Healthcare Fund has given a return of 16.13% in last five years and category average returns is 16.73% in same period. The fund ranked 5.0th out of six funds in the category. In the same period the Nifty Pharma TRI return was 14.52%. The fund has given 1.61% more return than the benchmark return.
  • The fund has given a return of 12.96% in last ten years and ranked 3.0rd out of three funds in the category. In the same period the Nifty Pharma TRI return was 7.65%. The fund has given 5.31% more return than the benchmark return.
  • The fund has given a SIP return of -2.26% in last one year whereas category average SIP return is -0.42%. The fund one year return rank in the category is 7th in 12 funds
  • The fund has SIP return of 14.45% in last three years and ranks 3rd in 5 funds. Mirae Asset Healthcare Fund has given the highest SIP return (15.98%) in the category in last three years.
  • The fund has SIP return of 15.98% in last five years whereas category average SIP return is 16.06%.

Uti Healthcare Fund Risk Analysis

  • The fund has a standard deviation of 15.79 and semi deviation of 11.03. The category average standard deviation is 15.51 and semi deviation is 10.99.
  • The fund has a Value at Risk (VaR) of -17.42 and a maximum drawdown of -15.36. The category average VaR is -18.18 and the maximum drawdown is -14.76. The fund has a beta of 0.88 which shows that fund is less volatile than the benchmark.

Standard deviation measures the fund's return volatility and Semi deviation focuses on downside volatility. Value at Risk (VaR) is a measure of the risk of investments. Maximum Drawdown is the maximum loss from a peak to a trough of a portfolio. Beta measures the volatility of the fund compared to the benchmark. A beta of 1 indicates that the fund will move in line with the benchmark. A beta of more than 1 indicates that the fund will be more volatile than the benchmark and vice versa.


  • Very Good Performance in Pharma Fund Category
  • Good Performance in Pharma Fund Category
  • Poor Performance in Pharma Fund Category
  • Very Poor Performance in Pharma Fund Category

    • Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

    Data Source: www.amfiindia.com

    SEBI Categorization


    KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
    1M Return % -0.96 2.94
    -0.25
    		-2.34 | 2.41 11 | 14 Average
    3M Return % -3.39 0.72
    -2.50
    		-5.86 | 0.84 9 | 14 Average
    6M Return % -6.34 3.11
    -4.13
    		-7.22 | -0.41 11 | 14 Average
    1Y Return % 8.27 12.80
    8.88
    		4.82 | 12.89 8 | 13 Good
    3Y Return % 25.26 26.24
    24.86
    		23.39 | 27.56 2 | 6 Very Good
    5Y Return % 14.94 14.52
    15.34
    		14.14 | 16.86 5 | 6 Average
    7Y Return % 18.52 14.92
    19.49
    		18.52 | 20.87 5 | 5 Average
    10Y Return % 11.84 7.65
    12.31
    		11.27 | 13.82 2 | 3 Good
    15Y Return % 14.26 12.35
    15.37
    		14.26 | 16.49 2 | 2 Good
    1Y SIP Return % -3.23
    -1.49
    		-6.58 | 4.05 8 | 13 Good
    3Y SIP Return % 13.26
    12.69
    		10.62 | 14.23 3 | 6 Good
    5Y SIP Return % 14.80
    14.56
    		13.45 | 16.51 3 | 6 Good
    7Y SIP Return % 17.40
    17.79
    		16.49 | 19.41 3 | 5 Good
    10Y SIP Return % 15.54
    15.82
    		15.37 | 16.55 2 | 3 Good
    15Y SIP Return % 14.07
    15.00
    		14.07 | 15.92 2 | 2 Good
    Standard Deviation 15.79
    15.51
    		14.34 | 16.43 5 | 8 Average
    Semi Deviation 11.03
    10.99
    		9.99 | 11.68 5 | 8 Average
    Max Drawdown % -15.36
    -14.76
    		-16.36 | -12.33 5 | 8 Average
    VaR 1 Y % -17.42
    -18.18
    		-21.68 | -15.67 4 | 8 Good
    Average Drawdown % -4.89
    -5.42
    		-6.79 | -3.66 3 | 8 Good
    Sharpe Ratio 1.22
    1.19
    		1.08 | 1.37 3 | 8 Good
    Sterling Ratio 1.02
    1.02
    		0.92 | 1.18 3 | 8 Good
    Sortino Ratio 0.65
    0.63
    		0.56 | 0.72 3 | 8 Good
    Jensen Alpha % 2.40
    1.56
    		-0.45 | 4.64 3 | 8 Good
    Treynor Ratio -0.41
    -0.42
    		-0.47 | -0.39 5 | 8 Average
    Modigliani Square Measure % 27.01
    26.49
    		24.56 | 29.65 3 | 8 Good
    Alpha % -0.49
    -1.30
    		-2.78 | 1.82 2 | 8 Very Good
    Return data last Updated On : March 13, 2026.
    Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Feb. 27, 2026
    KPIs: Key Performance Indicators

    Rotate the phone! Best viewed in landscape mode on mobile.
    KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
    1M Return % -0.88 2.94 -0.15 -2.22 | 2.53 11 | 14 Average
    3M Return % -3.16 0.72 -2.19 -5.70 | 1.19 9 | 14 Average
    6M Return % -5.89 3.11 -3.48 -6.75 | 0.40 11 | 14 Average
    1Y Return % 9.34 12.80 10.38 6.15 | 14.22 8 | 13 Good
    3Y Return % 26.49 26.24 26.32 24.88 | 28.62 3 | 6 Good
    5Y Return % 16.13 14.52 16.73 15.75 | 17.87 5 | 6 Average
    7Y Return % 19.72 14.92 20.91 19.72 | 22.39 5 | 5 Average
    10Y Return % 12.96 7.65 13.61 12.96 | 14.84 3 | 3 Average
    1Y SIP Return % -2.26 -0.42 -4.99 | 5.57 7 | 12 Average
    3Y SIP Return % 14.45 14.12 12.37 | 15.98 3 | 5 Good
    5Y SIP Return % 15.98 16.06 15.03 | 17.53 3 | 5 Good
    7Y SIP Return % 18.63 19.21 18.31 | 20.53 3 | 5 Good
    10Y SIP Return % 16.69 17.14 16.69 | 17.60 3 | 3 Average
    Standard Deviation 15.79 15.51 14.34 | 16.43 5 | 8 Average
    Semi Deviation 11.03 10.99 9.99 | 11.68 5 | 8 Average
    Max Drawdown % -15.36 -14.76 -16.36 | -12.33 5 | 8 Average
    VaR 1 Y % -17.42 -18.18 -21.68 | -15.67 4 | 8 Good
    Average Drawdown % -4.89 -5.42 -6.79 | -3.66 3 | 8 Good
    Sharpe Ratio 1.22 1.19 1.08 | 1.37 3 | 8 Good
    Sterling Ratio 1.02 1.02 0.92 | 1.18 3 | 8 Good
    Sortino Ratio 0.65 0.63 0.56 | 0.72 3 | 8 Good
    Jensen Alpha % 2.40 1.56 -0.45 | 4.64 3 | 8 Good
    Treynor Ratio -0.41 -0.42 -0.47 | -0.39 5 | 8 Average
    Modigliani Square Measure % 27.01 26.49 24.56 | 29.65 3 | 8 Good
    Alpha % -0.49 -1.30 -2.78 | 1.82 2 | 8 Very Good
    Return data last Updated On : March 13, 2026.
    Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Feb. 27, 2026
    KPIs: Key Performance Indicators

    Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


    Date Uti Healthcare Fund NAV Regular Growth Uti Healthcare Fund NAV Direct Growth
    13-03-2026 276.6485 313.9209
    12-03-2026 281.9918 319.9755
    11-03-2026 282.8978 320.9949
    10-03-2026 282.415 320.4384
    09-03-2026 278.0316 315.4564
    06-03-2026 280.3129 318.0192
    05-03-2026 281.219 319.0386
    04-03-2026 278.1688 315.5697
    02-03-2026 282.3311 320.2744
    27-02-2026 284.7853 323.0324
    26-02-2026 287.8636 326.5154
    25-02-2026 285.3176 323.6188
    24-02-2026 282.3509 320.2453
    23-02-2026 282.4666 320.3679
    20-02-2026 280.1185 317.6791
    19-02-2026 280.6602 318.2849
    18-02-2026 282.6386 320.52
    17-02-2026 281.9981 319.7851
    16-02-2026 280.1378 317.667
    13-02-2026 279.3164 316.71

    Fund Launch Date: 27/May/1999
    Fund Category: Pharma Fund
    Investment Objective: The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equities and equity related securities of companies/ institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.
    Fund Description: An open ended equity scheme investing in the Healthcare Services Sector
    Fund Benchmark: S&P BSE Healthcare
    Source: Fund FactSheet

    Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.